The neurosurgery and brain repair at the University of South Florida has a patent for a new procedure that uses blood cord to treat neurodegenerative conditions and diseases. The use of cord blood combined with mannitol, technology can help treat diseases that cause brain function to deteriorate, including Parkinson's disease, multiple sclerosis, stroke and Alzheimer ' Alzheimer.
The new procedure was authorized by Saneron CCEL Therapeutics Inc., a research and development firm specializing in biotechnology.
Previously, treatment of cord blood could not be used to its full potential in the treatment of injuries or brain diseases, because of the blood-brain barrier prevents the stem cells from passing into the brain . The new technology of South Florida University will be able to get the cells through the blood-brain barrier, mannitol shrinks the cells that make up the barrier. This allows the cord blood to reach its destination in the brain.
Cord blood has long been used to treat a variety of blood diseases such as leukemia and sickle cell anemia, but the prospect of treating brain injury has yet to be fully explored. Many clinical trials have been held, but cord blood therapy has not become an acceptable form of treatment for neurological disorders, although one of the main areas where UCB has proven useful is in the treatment of Cerebral Palsey. The company hopes that this patent will pave the way for other products and therapies that may also help reduce and repair damage to the brain.